Literature DB >> 33811275

Prognostic impact of extranodal extension in patients with pN1-N2 lung adenocarcinoma.

Kotaro Nomura1,2,3, Keiju Aokage2, Tokiko Nakai1, Shingo Sakashita1, Tomohiro Miyoshi2, Kenta Tane2, Joji Samejima2, Kenji Suzuki3, Masahiro Tsuboi2, Genichiro Ishii4,5.   

Abstract

PURPOSE: Lymph node involvement is one of the important prognostic factors of patients with lung adenocarcinoma. In the tumor, node, and metastasis classification, lymph node involvement is categorized only according to the anatomical station and not the involvement pattern. The aim of this study was to investigate which morphological pattern of lymph node involvement affects the prognosis of patients with surgically resected lung adenocarcinoma.
METHODS: We retrospectively reviewed 168 consecutive patients who underwent surgical resection for primary lung adenocarcinoma with lymph node involvement. The morphological patterns of lymph node involvement (tumor area, number of metastatic lymph nodes, presence of necrosis, and extranodal extension) were histologically examined. The relationships between the patterns of lymph node involvement, clinicopathological features, and survival of patients were analyzed.
RESULTS: Eighty patients had N1 disease, and 88 patients had N2 disease. Univariate analysis revealed that invasive size, history of adjuvant chemotherapy, and presence of extranodal extension were significant prognostic factors in N1 patients, and vascular invasion, pleural invasion, presence of epidermal growth factor receptor mutation, history of adjuvant chemotherapy, and presence of extranodal extension were significant prognostic factors in N2 patients. In a bivariate analysis including other clinicopathological factors and patterns of lymph node involvement, the presence of extranodal extension was significantly associated with poor 3-year overall and recurrence-free survival of both N1 and N2 patients.
CONCLUSIONS: In patients who underwent surgical resection for lung adenocarcinoma with lymph node involvement, the extranodal extension was the most important prognostic factor among morphological lymph node involvement patterns.

Entities:  

Keywords:  Extranodal extension; Lung adenocarcinoma; Lymph node involvement; Prognosis

Year:  2021        PMID: 33811275     DOI: 10.1007/s00432-021-03608-4

Source DB:  PubMed          Journal:  J Cancer Res Clin Oncol        ISSN: 0171-5216            Impact factor:   4.553


  24 in total

Review 1.  Lung cancer.

Authors:  Roy S Herbst; John V Heymach; Scott M Lippman
Journal:  N Engl J Med       Date:  2008-09-25       Impact factor: 91.245

2.  Lymph-node ratio predicts survival among the different stages of non-small-cell lung cancer: a multicentre analysis†.

Authors:  Marco Chiappetta; Giovanni Leuzzi; Isabella Sperduti; Emilio Bria; Felice Mucilli; Filippo Lococo; Lorenzo Spaggiari; Giovanni Battista Ratto; Pier Luigi Filosso; Francesco Facciolo
Journal:  Eur J Cardiothorac Surg       Date:  2019-03-01       Impact factor: 4.191

3.  Lung Adenocarcinoma has a Higher Risk of Lymph Node Metastasis than Squamous Cell Carcinoma: A Propensity Score-Matched Analysis.

Authors:  Han-Yu Deng; Miao Zeng; Gang Li; Guha Alai; Jun Luo; Lun-Xu Liu; Qinghua Zhou; Yi-Dan Lin
Journal:  World J Surg       Date:  2019-03       Impact factor: 3.352

4.  Adjuvant cisplatin and vinorelbine for completely resected non-small cell lung cancer: subgroup analysis of the Lung Adjuvant Cisplatin Evaluation.

Authors:  Jean-Yves Douillard; Hélène Tribodet; Delphine Aubert; Frances A Shepherd; Rafael Rosell; Keyue Ding; Anne-Sophie Veillard; Lesley Seymour; Thierry Le Chevalier; Stephen Spiro; Richard Stephens; Jean Pierre Pignon
Journal:  J Thorac Oncol       Date:  2010-02       Impact factor: 15.609

5.  Significance of the number of positive lymph nodes in resected non-small cell lung cancer.

Authors:  Takayuki Fukui; Shoichi Mori; Kohei Yokoi; Tetsuya Mitsudomi
Journal:  J Thorac Oncol       Date:  2006-02       Impact factor: 15.609

6.  Lymph node blood vessels provide exit routes for metastatic tumor cell dissemination in mice.

Authors:  M Brown; F P Assen; A Leithner; J Abe; H Schachner; G Asfour; Z Bago-Horvath; J V Stein; P Uhrin; M Sixt; D Kerjaschki
Journal:  Science       Date:  2018-03-23       Impact factor: 47.728

7.  Impact of postoperative radiation therapy on survival in patients with complete resection and stage I, II, or IIIA non-small-cell lung cancer treated with adjuvant chemotherapy: the adjuvant Navelbine International Trialist Association (ANITA) Randomized Trial.

Authors:  Jean-Yves Douillard; Rafael Rosell; Mario De Lena; Marcello Riggi; Patrick Hurteloup; Marc-Andre Mahe
Journal:  Int J Radiat Oncol Biol Phys       Date:  2008-04-24       Impact factor: 7.038

Review 8.  The International Association for the Study of Lung Cancer Lung Cancer Staging Project: Proposals for the Revision of the N Descriptors in the Forthcoming 8th Edition of the TNM Classification for Lung Cancer.

Authors:  Hisao Asamura; Kari Chansky; John Crowley; Peter Goldstraw; Valerie W Rusch; Johan F Vansteenkiste; Hirokazu Watanabe; Yi-Long Wu; Marcin Zielinski; David Ball; Ramon Rami-Porta
Journal:  J Thorac Oncol       Date:  2015-12       Impact factor: 15.609

9.  The IASLC Lung Cancer Staging Project: A Renewed Call to Participation.

Authors:  Dorothy J Giroux; Paul Van Schil; Hisao Asamura; Ramón Rami-Porta; Kari Chansky; John J Crowley; Valerie W Rusch; Kemp Kernstine
Journal:  J Thorac Oncol       Date:  2018-02-22       Impact factor: 15.609

10.  Feasibility of nodal classification for non-small cell lung cancer by merging current N categories with the number of involved lymph node stations.

Authors:  Wei Chen; Chenlei Zhang; Gebang Wang; Zhanwu Yu; Hongxu Liu
Journal:  Thorac Cancer       Date:  2019-06-17       Impact factor: 3.500

View more
  3 in total

1.  18F-fluorodeoxyglucose uptake in PET is associated with the tumor microenvironment in metastatic lymph nodes and prognosis in N2 lung adenocarcinoma.

Authors:  Kotaro Nomura; Tokiko Nakai; Yukino Nishina; Naoya Sakamoto; Tomohiro Miyoshi; Kenta Tane; Joji Samejima; Keiju Aokage; Motohiro Kojima; Shingo Sakashita; Tetsuro Taki; Saori Miyazaki; Reiko Watanabe; Kenji Suzuki; Masahiro Tsuboi; Genichiro Ishii
Journal:  Cancer Sci       Date:  2022-02-18       Impact factor: 6.716

2.  Muscle Quality Predicts Outcomes after Surgery for Early-Stage Non-Small-Cell Lung Cancer.

Authors:  Atsushi Kamigaichi; Hiroaki Harada; Satoshi Shibata
Journal:  Ann Thorac Cardiovasc Surg       Date:  2022-03-16       Impact factor: 1.889

3.  The Evolving Concept of Complete Resection in Lung Cancer Surgery.

Authors:  Ramón Rami-Porta
Journal:  Cancers (Basel)       Date:  2021-05-25       Impact factor: 6.639

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.